Glycosylated Components of the Mycobacterial Cell Wall: Structure and Function

Microbial Glycobiology

Volumn , Issue , 2010, Pages 147-167

  Chatterjee, Delphi ^a   Brennan, Patrick J ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84863482656     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374546-0.00009-2     Document Type: Chapter

References (128)

1. Adam A., Petit J.F., Wietzerbin-Falszpan J., Sinay P., Thomas D.W., Lederer E. L'acide N-glycolyl-muramique, constituant des parois de Mycobacterium smegmatis: identification par spectrometrie de masse. FEBS Lett. 1969, 4:87-92.
2. Anderson R.J. The chemistry of the lipids of the tubercle bacillus and certain other microorganisms. Prog. Chem. Org. Nat. Prod. 1939, 3:145-202.
3. Aspinall G.O., Chatterjee D., Brennan P.J. The variable surface glycolipids of mycobacteria: structures, synthesis of epitopes, and biological properties. Advances in Carbohydrate Chemistry and Biochemistry 1995, vol. 51:169-242. Academic Press, Washington DC. D. Horton (Ed.).
4. Azuma I., Kimura H., Ninaka T., Aoki I., Yamamura Y. Chemical and immunological studies on mycobacterial polysaccharides. I. Purification and properties of polysaccharides from human tubercle bacilli. J. Bacteriol. 1968, 95:263-271.
5. Ballou C.E., Lee Y.C. The structure of a myo-inositol mannoside from Mycobacterium tuberculosis glycolipid. Biochemistry 1964, 3:682-685.
6. Barrow W.W., Brennan P.J. Immunogenicity of type-specific C-mycoside glycopeptidolipids of mycobacteria. Infect. Immun. 1982, 36:678-684.
7. Beatty W.L., Rhoades E.R., Ullrich H.J., Chatterjee D., Heuser J.E., Russell D.G. Trafficking and release of mycobacterial lipids from infected macrophages. Traffic 2000, 1:235-247.
8. Besra G.S., Sievert T., Lee R.E., Slayden R.A., Brennan P.J., Takayama K. Identification of the apparent carrier in mycolic acid synthesis. Proc. Natl. Acad. Sci. USA 1994, 91:12735-12739.
9. 1H nuclear magnetic resonance spectroscopy. Biochemistry 1995, 34:4257-4266.
10. Besra G.S., Morehouse C.B., Rittner C.M., Waechter C.J., Brennan P.J. Biosynthesis of mycobacterial lipoar-abinomannan. J. Biol. Chem. 1997, 272:18460-18466.
11. Bhamidi S., Scherman M.S., Rithner C.D., et al. The identification and location of succinyl residues and the characterization of the interior arabinan region allow for a model of the complete primary structure of Mycobacterium tuberculosis mycolyl arabinogalactan. J. Biol. Chem. 2008, 283:12992-13000.
12. Bloch H. Studies on the virulence of tubercle bacilli; isolation and biological properties of a constituent of virulent organisms. J. Exp. Med. 1950, 91:197-218.
13. Brennan P.J. Mycobacterium and other actinomycetes. Mycobacterial Lipids 1988, vol. I:203-298. Academic Press, London. R.C. Wilkinson, S.G. Wilkinson (Eds.).
14. Brennan P.J. Structure of mycobacteria: recent developments in defining cell wall carbohydrates and proteins. Rev. Infect. Dis. 1989, 11:S420-S430.
15. Brennan P.J., Ballou C.E. Biosynthesis of mannophosphoinositides by Mycobacterium phlei. The family of dimannosylphosphoinositides. J. Biol. Chem. 1967, 242:3046-3056.
16. Brennan P.J., Ballou C.E. Biosynthesis of mannophosphoinositides by Mycobacterium phlei. Enzymatic acylation of the dimannophosphoinositides. J. Biol. Chem. 1968, 243:2975-2984.
17. Brennan P.J., Crick D.C. The cell-wall core of Mycobacterium tuberculosis in the context of drug discovery. Curr. Top. Med. Chem. 2007, 7:475-488.
18. Brennan P.J., Goren M.B. Structural studies on the type-specific antigens and lipids of the Mycobacterium avium-Mycobacterium intracellulare Mycobacterium scrofulaceum complex serocomplex. J. Biol. Chem. 1979, 254:4205-4211.
19. Brennan P.J., Nikaido H. The envelope of mycobacteria. Annu. Rev. Biochem. 1995, 64:29-63.
20. Brennan P.J., Heifets M., Ullom B.P. Thin-layer chromatography of lipid antigens as a means of identifying non-tuberculous mycobacteria. J. Clin. Microbiol. 1982, 15:447-455.
21. Brennan P.J., Mayer H., Aspinall G.O., Nam Shin J.E. Structures of the glycopeptidolipid antigens from serovars in the Mycobacterium avium/Mycobacterium intracellulare/Mycobacterium scrofulaceum serocomplex. Eur. J. Biochem. 1981, 115:7-15.
22. Briken V., Porcelli S.A., Besra G.S., Kremer L. Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. Mol. Microbiol. 2004, 53:391-403.
23. Chaput M., Michel G., Lederer E. On the mycoside Cm, a new peptido-glycolipid isolated from Mycobacterium marianum. Experientia 1961, 17:107-108.
24. Chaput M., Michel G., Lederer E. [Structure of mycoside Cm, peptidoglycolipid of Mycobacterium marianum]. Biochim. Biophys. Acta 1962, 63:310-326.
25. Chaput M., Michel G., Lederer E. [Structure of mycoside C2 of Mycobacterium Avium]. Biochim. Biophys. Acta 1963, 78:329-341.
26. Chatterjee D., Khoo K.H. Mycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effects. Glycobiology 1998, 8:113-120.
27. Chatterjee D., Khoo K.-H. The surface glycopeptidolipids of mycobacteria:structures and biological properties. Cell. Mol. Life Sci. 2001, 58:2018-2042.
28. Chatterjee D., Bozic C.M., Knisley C., Cho S.N., Brennan P.J. Phenolic glycolipids of Mycobacterium bovis: new structures and synthesis of a corresponding seroreactive neoglycoprotein. Infect. Immun. 1989, 57:322-330.
29. Chatterjee D., Bozic C.M., McNeil M., Brennan P.J. Structural features of the arabinan component of the lipoarabinomannan of Mycobacterium tuberculosis. J. Biol. Chem. 1991, 266:9652-9660.
30. Chatterjee D., Hunter S.W., McNeil M., Brennan P.J. Lipoarabinomannan. Multiglycosylated form of the mycobacterial mannosylphophatidylinositols. J. Biol. Chem. 1992, 267:6228-6233.
31. Chatterjee D., Roberts A.D., Lowell K., Brennan P.J., Orme I.M. Structural basis of capacity of lipoarabinomannan to induce secretion of tumor necrosis factor. Infect. Immun. 1992, 60:1249-1253.
32. Chen Q., Brglez I., Boss W.F. Inositol phospholipids as plant second messengers. Symp. Soc. Exp. Biol. 1991, 45:159-175.
33. Daffe M., Draper P. The envelope layers of mycobacteria with reference to their pathogenicity. Adv. Microb. Physiol. 1998, 39:131-203.
34. Daffe M., Laneelle M.A. Diglycosyl phenol phthiocerol diester of Mycobacterium leprae. Biochim. Biophys. Acta 1989, 1002:333-337.
35. Daffe M., Cho S.N., Chatterjee D., Brennan P.J. Chemical synthesis and seroreactivity of a neoantigen containing the oligosaccharide hapten of the Mycobacterium tuberculosis-specific phenolic glycolipid. J. Infect. Dis. 1991, 163:161-168.
36. de la Salle H., Mariotti S., Angenieux C., et al. Assistance of microbial glycolipid antigen processing by CD1e. Science 2005, 310:1321-1324.
37. Delmas C., Gilleron M., Brando T., et al. Comparative structural study of the mannosylated-lipoarabinomannans from Mycobacterium bovis BCG vaccine strains: characterization and localization of succinates. Glycobiology 1997, 7:811-817.
38. Dobson G., Minnikin D.E., Besra G.S., Mallet A.I., Magnusson M. Characterisation of phenolic glycolipids from Mycobacterium marinum. Biochim. Biophys. Acta 1990, 1042:176-181.
39. Draper P., Kandler O., Darbre A. Peptidoglycan and arabinogalactan of Mycobacterium leprae. J. Gen. Microbiol. 1987, 133:1187-1194.
40. Draper P., Khoo K.H., Chatterjee D., Dell A., Morris H.R. Galactosamine in walls of slow-growing mycobacteria. Biochem. J. 1997, 327:519-525.
41. Etienne G., Villeneuve C., Billman-Jacobe H., Astarie-Dequeker C., Dupont M.A., Daffe M. The impact of the absence of glycopeptidolipids on the ultrastructure, cell surface and cell wall properties, and phagocytosis of Mycobacterium smegmatis. Microbiology 2002, 148:3089-3100.
42. Fischer K., Scotet E., Niemeyer M., et al. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc. Natl. Acad. Sci. USA 2004, 101:10685-10690.
43. Frehel C., Rastogi N. Phagosome-lysosome fusions in macrophages infected by Mycobacterium avium: role of mycosides-C and other cells surface components. Acta Leprol. 1989, 7(Suppl. 1):173-174.
44. Gastambide-Odier M., Lederer E., Sarda P. [Structure of the aglycones of mycosides A and B]. Tetrahedron. Lett. 1965, 35:3135-3143.
45. Gaylord H., Brennan P.J. Leprosy and the leprosy bacillus: recent developments in characterization of antigens and immunology of the disease. Annu. Rev. Microbiol. 1987, 41:645-675.
46. Gibson K.J., Gilleron M., Constant P., et al. A lipomannan variant with strong TLR-2-dependent proinflammatory activity in Saccharothrix aerocolonigenes. J. Biol. Chem. 2005, 280:28347-28356.
47. Gilleron M., Himoudi N., Adam O., et al. Mycobacterium smegmatis phosphatidylinositols-glyceroarabinomannans. J. Biol. Chem. 1997, 272:117-124.
48. Gilleron M., Quesniaux V.F., Puzo G. Acylation state of the phosphatidylinositol hexamannosides from Mycobacterium bovis bacillus Calmette Guerin and Mycobacterium tuberculosis H37Rv and its implication in Toll-like receptor response. J. Biol. Chem. 2003, 278:29880-29889.
49. Gilleron M., Nigou J., Nicolle D., Quesniaux V., Puzo G. The acylation state of mycobacterial lipomannans modulates innate immunity response through Toll-like receptor 2. Chem. Biol. 2006, 13:39-47.
50. Goren M.B. Mycobacterial lipids: selected topics. Bacteriol. Rev. 1972, 36:33-64.
51. Goren M.B., Brennan P.J. Mycobacterial lipids: chemistry and biological activities. Tuberculosis 1979, 69-193. W.B. Saunders, Philadelphia. G.P. Youmans (Ed.).
52. Goren M.B., D'Arcy Hart P., Young M.R., Armstrong J.A. Prevention of phagosome-lysosome fusion in cultured macrophages by sulfatides of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 1976, 73:2510-2514.
53. Guerardel Y., Maes E., Briken V., et al. Lipomannan and lipoarabinomannan from a clinical isolate of Mycobacterium kansasii: novel structural features and apoptosis-inducing properties. J. Biol. Chem. 2003, 278:36637-36651.
54. Heidelberger M. Quantitative absolute methods in the study of antigen-antibody reactions. Bacteriol. Rev. 1939, 3:49-95.
55. Henderson B., Poole S., Wilson M. Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol. Rev. 1996, 60:316-341.
56. Hoffmann C., Leis A., Niederweis M., Plitzko J.M., Engelhardt H. Disclosure of the mycobacterial outer membrane: cryo-electron tomography and vitreous sections reveal the lipid bilayer structure. Proc. Natl. Acad. Sci. USA 2008, 105:3963-3967.
57. Hunter S.W., Brennan P.J. A novel phenolic glycolipid from Mycobacterium leprae possibly involved in immunogenicity and pathogenicity. J. Bacteriol. 1981, 147:728-735.
58. Hunter S.W., Brennan P.J. Evidence for the presence of a phosphatidylinositol anchor on the lipoarabinomannan and lipomannan of Mycobacterium tuberculosis. J. Biol. Chem. 1990, 265:9272-9279.
59. Hunter S.W., Murphy R.C., Clay K., Goren M.B., Brennan P.J. Trehalose-containing lipooligosaccharides. A new class of species-specific antigens from Mycobacterium. J. Biol. Chem. 1983, 258:10481-10487.
60. Hunter S.W., Fujiwara T., Murphy R.C., Brennan P.J. N-acylkansosamine. A novel N-acylamino sugar from the trehalose-containing lipooligosaccharide antigens of Mycobacterium kansasii. J. Biol. Chem. 1984, 259:9729-9734.
61. Hunter S.W., Gaylord H., Brennan P.J. Structure and antigenicity of the phosphorylated lipopolysaccharide antigens from the leprosy and tubercle bacilli. J. Biol. Chem. 1986, 261:12345-12351.
62. Ilangumaran S., Arni S., Poincelet M., et al. Integration of mycobacterial lipoarabinomannans into glycosylphosphatidylinositol-rich domains of lymphomonocytic cell plasma membranes. J. Immunol. 1995, 155:1334-1342.
63. Jenkins P.A., Marks J., Schaefer W.B. Lipid chromatography and seroagglutination in the classification of rapidly growing mycobacteria. Am. Rev. Respir. Dis. 1971, 103:179-187.
64. Jullien D., Stenger S., Ernst W.A., Modlin R.L. CD1 presentation of microbial nonpeptide antigens to T cells. J. Clin. Invest. 1997, 99:2071-2074.
65. Kato M., Asselineau J. Chemical structure and biochemical activity of cord factor analogs. 6,6′-Dimycoloyl sucrose and methyl 6-mycoloyl-d-glucoside. Eur. J. Biochem. 1971, 22:364-370.
66. Khoo K.-H., Dell A., Morris H.R., Brennan P.J., Chatterjee D. Inositol phosphate capping of the nonreducing termini of lipoarabinomannan from rapidly growing strains of Mycobacterium. J. Biol. Chem. 1995, 270:12380-12389.
67. Khoo K.-H., Dell A., Morris H.R., Brennan P.J., Chatterjee D. Structural definition of acylated phosphatidylinositol mannosides from Mycobacterium tuberculosis: definition of a common anchor for lipomannan and lipoarabinomannan. Glycobiology 1995, 5:117-127.
68. Khoo K.H., Douglas E., Azadi P., et al. Truncated structural variants of lipoarabinomannan in ethambutol drug-resistant strains of Mycobacterium smegmatis - inhibition of arabinan biosynthesis by ethambutol. J. Biol. Chem. 1996, 271:28682-28690.
69. Klutts J.S., Hatanaka K., Pan Y.T., Elbein A.D. Biosynthesis of d-arabinose in Mycobacterium smegmatis: specific labeling from d-glucose. Arch. Biochem. Biophys. 2002, 398:229-239.
70. Lee A., Wu S.W., Scherman M.S., et al. Sequencing of oligoarabinosyl units released from mycobacterial arabinogalactan by endogenous arabinanase: identification of distinctive and novel structural motifs. Biochemistry 2006, 45:15817-15828.
71. Lee Y.C., Ballou C.E. Structural studies on the myo-inositol mannosides from the glycolipids of Mycobacterium tuberculosis and Mycobacterium phlei. J. Biol. Chem. 1964, 239:1316-1327.
72. Lee Y.C., Ballou C.E. Complete structures of the glycophospholipids of mycobacteria. Biochemistry 1965, 4:1395-1404.
73. Leopold K., Fischer W. Molecular analysis of the lipoglycans of Mycobacterium tuberculosis. Anal. Biochem. 1993, 208:57-64.
74. Maclennan A.P., Randall H.M., Smith D.W. The occurence of methyl ethers of rhamose and fucose in specific glycolipids of certain mycobacteria. Biochem. J. 1961, 80:309-318.
75. Maeda N., Nigou J., Herrmann J.L., et al. The cell surface receptor DC-SIGN discriminates between Mycobacterium species through selective recognition of the mannose caps on lipoarabinomannan. J. Biol. Chem. 2003, 278:5513-5516.
76. Mahapatra S., Crick D.C., McNeil M.R., Brennan P.J. Unique structural features of the peptidoglycan of Mycobacterium leprae. J. Bacteriol. 2008, 190:655-661.
77. Marks J., Jenkins P.A., Schaefer W.B. Identification and incidence of a third type of Mycobacterium avium. Am. Rev. Respir. Dis. 1970, 102:499-506.
78. Marks J., Jenkins P.A., Schaefer W.B. Thin-layer chromatography of mycobacterial lipids as an aid to classification: technical improvements: Mycobacterium avium, M. intracellulare (Battey bacilli). Tubercle 1971, 52:219-225.
79. Martinez A., Torello S., Kolter R. Sliding motility in mycobacteria. J. Bacteriol. 1999, 181:7331-7338.
80. Matsuhashi M. [Biosynthesis in the bacterial cell wall]. Tanpakushitsu Kakusan Koso 1966, 11:875-886.
81. McNeil M., Tsang A.Y., McClatchy J.K., Stewart C., Jardine I., Brennan P.J. Definition of the surface antigens of Mycobacterium malmoense and use in studying the etiology of a form of mycobacteriosis. J. Bacteriol. 1987, 169:3312-3320.
82. McNeil M., Daffe M., Brennan P.J. Location of the mycolyl ester substituents in the cell walls of mycobacteria. J. Biol. Chem. 1991, 266:13217-13223.
83. Middlebrook G., Colemann C., Schaeffer W.B. Sulfolipids from virulent tubercle bacilli. Proc. Natl. Acad. Sci. USA 1959, 45:1801-1804.
84. Minnikin D.E. Lipids: complex lipids, their chemistry, biosynthesis and roles. The Biology of Mycobacteria 1982, vol. 2:95-184. Academic Press, London. C. Ratledge, J. Stanford (Eds.).
85. Misaki A., Seto N., Azuma I. Structure and immunological properties if d-arabino-d-galactan isolated from cell walls of Mycobacterium species. J. Biochem. 1974, 76:15-27.
86. Misaki A., Azuma I., Yamamura Y. Structural and immunochemical studies on d-arabino-d-mannans and d-mannans of Mycobacterium tuberculosis and other Mycobacterium species. J. Biochem. 1977, 82:1759-1770.
87. Moehring J.M., Solotorovsky M.R. Relationship of colonial morphology to virulence for chickens of Mycobacterium avium and the nonphotochromogens. Am. Rev. Respir. Dis. 1965, 92:704-713.
88. Ng V., Zanazzi G., Timpl R., et al. Role of the cell wall phenolic glycolipid-1 in the peripheral nerve predilection of Mycobacterium leprae. Cell 2000, 103:511-524.
89. Noll H., Jackim E. The chemistry of the native constituents of the acetone-soluble fat of Mycobacterium tuberculosis (Brevannes). I. Glycerides and phosphoglycolipides. J. Biol. Chem. 1958, 232:903-917.
90. Noll H., Bloch H., Asselineau J., Lederer E. The chemical structure of the cord factor of Mycobacterium tuberculosis. Biochim. Biophys. Acta 1956, 20:299-309.
91. Ortalo-Magné A., Lemassu A., Lanéelle M.A., et al. Identification of the surface-exposed lipids on the cell envelopes of Mycobacterium tuberculosis and other mycobacterial species. J. Bacteriol. 1996, 178:456-461.
92. Pabst M.J., Gross J.M., Brozna J.P., Goren M.B. Inhibition of macrophage priming by sulfatide from Mycobacterium tuberculosis. J. Immunol. 1988, 140:634-640.
93. Pangborn M.C., McKinney J.A. Purification of serologically active phosphoinositides of Mycobacterium tuberculosis. J. Lipid Res. 1966, 7:627-633.
94. Patterson J.H., McConville M.J., Haites R.E., Coppel R.L., Billman-Jacobe H. Identification of a methyltransferase from Mycobacterium smegmatis involved in glycopeptidolipid synthesis. J. Biol. Chem. 2000, 275:24900-24906.
95. Prigozy T.I., Sieling P.A., Clemens D., et al. The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity 1997, 6:187-197.
96. Prinzis S., Chatterjee D., Brennan P.J. Structure and antigenicity of lipoarabinomannan from Mycobacterium bovis BCG. J. Gen. Microbiol. 1993, 139:2649-2658.
97. Recht J., Martinez A., Torello S., Kolter R. Genetic analysis of sliding motility in Mycobacterium smegmatis. J. Bacteriol. 2000, 182:4348-4351.
98. Saadat S., Ballou C.E. Pyruvylated glycolipids from Mycobacterium smegmatis. Structures of two oligosaccharide components. J. Biol. Chem. 1983, 258:1813-1818.
99. Schaefer W.B. Serologic identification and classification of the atypical mycobacteria by their agglutination. Am. Rev. Respir. Dis. 1965, 92:85-93.
100. Schaefer W.B., Davis C.L., Cohn M.L. Pathogenicity of transparent, opaque, and rough variants of Mycobacterium avium in chickens and mice. Am. Rev. Respir. Dis. 1970, 102:499-506.
101. Scherman M., Weston A., Duncan K., et al. The biosynthetic origin of the mycobacterial cell wall arabinosyl residues. J. Bacteriol. 1995, 177:7125-7130.
102. Scherman M.S., Kalbe-Bournonville L., Bush D., Xin Y., Deng L., McNeil M. Polyprenylphosphate-pentoses in mycobacteria are synthesized from 5-phosphoribose pyrophosphate. J. Biol. Chem. 1996, 271:29652-29658.
103. Schlesinger L.S. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J. Immunol. 1993, 150:2920-2925.
104. Schlesinger L.S., Hull S.R., Kaufman T.M. Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages. J. Immunol. 1994, 152:4070-4079.
105. Schlesinger L.S., Kaufman T.M., Iyer S., Hull S.R., Marchiando L.K. Differences in mannose receptor-mediated uptake of lipoarabinomannan from virulent and attenuated strains of Mycobacterium tuberculosis by human macrophages. J. Immunol. 1996, 157:4568-4575.
106. Schultz J., Elbein A.D. Biosynthesis of mannosyl- and glucosyl-phosphoryl polyprenols in Mycobacterium smegmatis. Evidence for oligosaccharide-phosphoryl-polyprenols. Arch. Biochem. Biophys. 1974, 160:311-322.
107. Severn W.B., Furneaux R.H., Falshaw R., Atkinson P.H. Chemical and spectroscopic characterisation of the phosphatidylinositol manno-oligosaccharides from Mycobacterium bovis AN5 and WAg201 and Mycobacterium smegmatis mc2 155. Carbohydr. Res. 1998, 308:397-408.
108. Sieling P.A., Chatterjee D., Porcelli S.A., et al. CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 1995, 269:227-230.
109. Smith D.W., Harrell W.K., Randall H.M. Correlation of biologic properties of strains of Mycobacterium with infrared spectrum III, differentiation of bovine and human varieties of M. tuberculosis by means of infrared spectrum. Am. Rev. Tuberc. 1954, 69:505-510.
110. Smith D.W., Randall H.M., MacLennan A.P., Putney R.K., Rao S.V. Detection of specific lipids in mycobacteria by infrared spectroscopy. J. Bacteriol. 1960, 79:217-229.
111. Smith D.W., Randall H.M., MaclLennan A.P., Lederer E. Mycosides: a new class of type specific glycolipids of mycobacteria. Nature (London) 1960, 186:887-888.
112. Stenger S., Mazzaccaro R.J., Uyemura K., et al. Differential effects of cytolytic T cell subsets on intracellular infection. Science 1997, 276:1684-1687.
113. Strohmeier G.R., Fenton M.J. Roles of lipoarabinomannan in the pathogenesis of tuberculosis. Microb. Infect. 1999, 1:709-717.
114. Sweet L., Zhang W., Torres-Fewell H., Serianni A., Boggess W., Schorey J. Mycobacterium avium glycopeptidolipids require specific acetylation and methylation patterns for signaling through TLR2. J. Biol. Chem. 2008, 283:33221-33231.
115. Tailleux L., Schwartz O., Herrmann J.L., et al. DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J. Exp. Med. 2003, 197:121-127.
116. Takayama K., Goldman D.S. Pathway for the synthesis of mannophospholipids in Mycobacterium tuberculosis. Biochim. Biophys. Acta 1969, 176:196-198.
117. Takayama K., Goldman D.S. Enzymatic synthesis of mannosyl-1-phosphoryl-decaprenol by a cell-free system of Mycobacterium tuberculosis. J. Biol. Chem. 1970, 245:6251-6257.
118. Takayama K., Schnoes H.K., Semmler E.J. Characterization of the alkali-stable mannophospholipids of Mycobacterium smegmatis. Biochim. Biophys. Acta 1973, 316:212-221.
119. Taylor P.R., Gordon S., Martinez-Pomares L. The mannose receptor: linking homeostasis and immunity through sugar recognition. Trends Immunol. 2005, 26:104-110.
120. Torrelles J.B., Khoo K.H., Sieling P.A., et al. Truncated structural variants of lipoarabinomannan in Mycobacterium leprae and an ethambutol-resistant strain of Mycobacterium tuberculosis. J. Biol. Chem. 2004, 279:41227-41239.
121. Treumann A., Xidong F., McDonnell L., et al. 5-Methylthiopentose: a new substituent on lipoarabinomannan in Mycobacterium tuberculosis. J. Mol. Biol. 2002, 316:89-100.
122. Turnbull W.B., Shimizu K.H., Chatterjee D., Homans S.W., Treumann A. Identification of the 5-methylthiopentosyl substituent in Mycobacterium tuberculosis lipoarabinomannan. Angew. Chem. Int. Ed. Engl. 2004, 43:3918-3922.
123. Vergne I., Fratti R.A., Hill P.J., Chua J., Belisle J., Deretic V. Mycobacterium tuberculosis phagosome maturation arrest: mycobacterial phosphatidylinositol analog phosphatidylinositol mannoside stimulates early endosomal fusion. Mol. Biol. Cell 2004, 15:751-760.
124. Vilkas E., Lederer E. N-methylation of peptides by the method of Hakomori. Structure of mycoside Cbl. Tetrahedron Lett. 1968, 26:3089-3092.
125. Vollmer W., Höltje J.V. The architecture of the murein (peptidoglycan) in gram-negative bacteria: vertical scaffold or horizontal layer(s)?. J. Bacteriol. 2004, 186:5978-5987.
126. Wolucka B.A., McNeil M.R., de Hoffmann E., Chojnacki T., Brennan P.J. Recognition of the lipid intermediate for arabinogalactan/arabinomannan biosynthesis and its relation to the mode of action of ethambutol on mycobacteria. J. Biol. Chem. 1994, 269:23328-23335.
127. Yokoyama K., Ballou C.E. Synthesis of α-1-6 mannooligosaccharide in M. smegmatis. J. Biol. Chem. 1989, 264:21621-21628.
128. Zuber B., Chami M., Houssin C., Dubochet J., Griffiths G., Daffé M. Direct visualization of the outer membrane of mycobacteria and corynebacteria in their native state. J. Bacteriol. 2008, 190:5672-5680.